# EDGAR Filing Document

**Accession Number:** 0001116942
**File Stem:** 0000950170-25-102042
**Filing Date:** 2025-8
**Character Count:** 127655
**Document Hash:** fd0cc78dfbdea6ca2f69693902e5f106
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-25-102042.hdr.sgml**: 20250804

**ACCESSION NUMBER**: 0000950170-25-102042

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 72

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250804

**DATE AS OF CHANGE**: 20250804

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TTM TECHNOLOGIES INC
- **CENTRAL INDEX KEY:** 0001116942
- **STANDARD INDUSTRIAL CLASSIFICATION:** PRINTED CIRCUIT BOARDS [3672]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 911033443
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1229

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-31285
- **FILM NUMBER:** 251180682

**BUSINESS ADDRESS:**
- **STREET 1:** 200 EAST SANDPOINTE
- **STREET 2:** SUITE 400
- **CITY:** SANTA ANA
- **STATE:** CA
- **ZIP:** 92707
- **BUSINESS PHONE:** 7143273000

**MAIL ADDRESS:**
- **STREET 1:** 200 EAST SANDPOINTE
- **STREET 2:** SUITE 400
- **CITY:** SANTA ANA
- **STATE:** CA
- **ZIP:** 92707

?xml version='1.0' encoding='ASCII'? 10-Q

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, DC 20549** 

------

**Form** 10-Q

------

☑ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended** **June 30,** 2025

**Or**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from ____________ to____________**

**Commission File Number:** 000-31285

------

TTM TECHNOLOGIES, INC.

**(Exact name of registrant as specified in its charter)** 

------

---

| | |
|:---|:---|
| Delaware | 91-1033443 |
| **(State or other jurisdiction of**<br>**incorporation or organization)** | **(I.R.S. Employer**<br>**Identification No.)** |

---

200 East Sandpointe**,** Suite 400**,** Santa Ana**,** California 92707

**(Address of principal executive offices)** 

**(**714**)** 327-3000

**(Registrant's telephone number, including area code)** 

------

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**<u>Title of each class</u>** | &nbsp;&nbsp;**<u>Trading symbol(s)</u>** | &nbsp;&nbsp;**<u>Name of each exchange on which registered</u>** |
| &nbsp;&nbsp;Common Stock, $0.001 par value | &nbsp;&nbsp;TTMI | &nbsp;&nbsp;Nasdaq Global Select Market |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☑ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐  | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

As of July 31, 2025, there were outstanding 103,313,274 shares of the registrant's Common Stock, $0.001 par value.

------

**TTM TECHNOLOGIES, INC.**

**Form 10-Q**

**For the Quarter Ended June 30, 2025**

**TABLE OF CONTENTS** 

---

| | |
|:---|:---|
|  | **Page** |
| [**<u>PART I: FINANCIAL INFORMATION</u>**](#part_i_financial_information) | 3 |
| [<u>Item 1. Financial Statements (unaudited)</u>](#item_1_financial_statements_unaudited) | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Consolidated Condensed Balance Sheets as of June 30, 2025 and December 30, 2024</u>](#consolidated_condensed_balance_sheets) | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Consolidated Condensed Statements of Operations for the quarter and two quarters ended June 30, 2025 and July 1, 2024</u>](#consolidated_condensed_statements_operat) | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Consolidated Condensed Statements of Comprehensive Income for the quarter and two quarters ended June 30, 2025 and July 1, 2024</u>](#consolidated_condensed_statements_compre) | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Consolidated Condensed Statements of Stockholders' Equity for the</u>](#consolidated_condensed_statements_stockh)[<u>two quarters ended June 30, 2025 and July 1, 2024</u>](#consolidated_condensed_statements_stockh) | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Consolidated Condensed Statements of Cash Flows for the two quarters ended June 30, 2025 and July 1, 2024</u>](#consolidated_condensed_statements_cash_f) | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Notes to Consolidated Condensed Financial Statements</u>](#notes_to_consolidated_condensed_financia) | 8 |
| [<u>Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</u>](#item_2_managements_discussion_analysis_f) | 20 |
| [<u>Item 3. Quantitative and Qualitative Disclosures About Market Risk</u>](#item_3_quantitative_qualitative_disclosu) | 28 |
| [<u>Item 4. Controls and Procedures</u>](#item_4_controls_procedures) | 29 |
| [**<u>PART II: OTHER INFORMATION</u>**](#part_ii_or_information) | 30 |
| [<u>Item 1. Legal Proceedings</u>](#item_1_legal_proceedings) | 30 |
| [<u>Item 1A. Risk Factors</u>](#item_1a_risk_factors) | 30 |
| [<u>Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</u>](#item_2_unregistered_sales_of_equity) | 30 |
| [<u>Item 3. Defaults Upon Senior Securities</u>](#item_3_defaults_upon_senior_securities) | 30 |
| [<u>Item 4. Mine Safety Disclosures</u>](#item_4_mine_safety_disclosures) | 30 |
| [<u>Item 5. Other Information</u>](#item_5_other_information) | 30 |
| [<u>Item 6. Exhibits</u>](#item_6_exhibits) | 31 |
| [**<u>SIGNATURES</u>**](#signatures) | 32 |

---

------

**PART I. FINANCIAL INFORMATION** 

**Item 1. *Financial Statements (unaudited)*** 

**TTM TECHNOLOGIES, INC.** 

**Consolidated Condensed Balance Sheets**

**As of June 30, 2025 and December 30, 2024**

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **June 30, 2025** | **December 30, 2024** |
|  | **(Unaudited)** | **(Unaudited)** |
|  | **(In thousands, except par value)** | **(In thousands, except par value)** |
| **ASSETS** |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $447967 | $503932 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 495352 | 448611 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract assets | 424973 | 381382 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 250339 | 224985 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 57818 | 47834 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 1676449 | 1606744 |
| Property, plant, and equipment, net | 919219 | 869957 |
| Operating lease right-of-use assets | 82763 | 78252 |
| Goodwill | 670135 | 670135 |
| Definite-lived intangibles, net | 173371 | 191819 |
| Deposits and other non-current assets | 56019 | 55587 |
| Total assets | $3577956 | $3472494 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term debt, including current portion of long-term debt | $3805 | $3795 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 448063 | 406221 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract liabilities | 162130 | 170915 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued salaries, wages, and benefits | 101917 | 108149 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | 111838 | 119974 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 827753 | 809054 |
| Long-term debt, net of discount and issuance costs | 913339 | 914359 |
| Operating lease liabilities | 85985 | 77509 |
| Other long-term liabilities | 113959 | 107748 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total long-term liabilities | 1113283 | 1099616 |
| Commitments and contingencies (Note 14) |  |  |
| Equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.001 par value; 300,000 shares authorized, 115,173 and<br> 113,161 shares issued as of June 30, 2025 and December 30, 2024, <br> respectively; 103,309 and 101,997 shares outstanding as of <br> June 30, 2025 and December 30, 2024, respectively | 115 | 113 |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock – common stock at cost; 11,864 and 11,164 shares as of <br> June 30, 2025 and December 30, 2024, respectively | (175445) | (157570) |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 928714 | 910741 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 912130 | 838422 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (28594) | (27882) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 1636920 | 1563824 |
| Total liabilities and stockholders' equity | $3577956 | $3472494 |

---

See accompanying notes to consolidated condensed financial statements.

------

**TTM TECHNOLOGIES, INC.** 

**Consolidated Condensed Statements of Operations** 

**For the Quarter and Two Quarters Ended June 30, 2025 and July 1, 2024**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Quarter Ended** | **For the Quarter Ended** | **For the Two Quarters Ended** | **For the Two Quarters Ended** |
|  | **June 30, 2025** | **July 1, 2024** | **June 30, 2025** | **July 1, 2024** |
|  | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
|  | **(In thousands, except per share data)** | **(In thousands, except per share data)** | **(In thousands, except per share data)** | **(In thousands, except per share data)** |
| Net sales | $730621 | $605137 | $1379289 | $1175250 |
| Cost of goods sold | 582512 | 487910 | 1100208 | 954304 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 148109 | 117227 | 279081 | 220946 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling and marketing | 21316 | 19798 | 42587 | 40092 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 49719 | 38604 | 93493 | 82274 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 7009 | 8547 | 15073 | 15868 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of definite-lived intangibles | 6888 | 10256 | 13777 | 21685 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges | 1408 | 1036 | 2122 | 4974 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 86340 | 78241 | 167052 | 164893 |
| Operating income | 61769 | 38986 | 112029 | 56053 |
| Other (expense) income: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (11095) | (12219) | (22559) | (24543) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | (5149) | 3765 | (2954) | 13091 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense, net | (16244) | (8454) | (25513) | (11452) |
| Income before income taxes | 45525 | 30532 | 86516 | 44601 |
| Income tax provision | (3995) | (4180) | (12808) | (7783) |
| Net income | $41530 | $26352 | $73708 | $36818 |
| Earnings per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic earnings per share | $0.41 | $0.26 | $0.72 | $0.36 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted earnings per share | 0.40 | 0.25 | 0.70 | 0.35 |

---

See accompanying notes to consolidated condensed financial statements.

------

**TTM TECHNOLOGIES, INC.** 

**Consolidated Condensed Statements of Comprehensive Income**

**For the Quarter and Two Quarters Ended June 30, 2025 and July 1, 2024**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Quarter Ended** | **For the Quarter Ended** | **For the Two Quarters Ended** | **For the Two Quarters Ended** |
|  | **June 30, 2025** | **July 1, 2024** | **June 30, 2025** | **July 1, 2024** |
|  | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| Net income | $41530 | $26352 | $73708 | $36818 |
| Other comprehensive income (loss), net of tax: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension obligation |  |  | 1174 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation | 115 | (56) | 159 | (858) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash flow hedges | (914) | 60 | (2045) | 3012 |
| Other comprehensive (loss) income, net of tax | (799) | 4 | (712) | 2154 |
| Comprehensive income, net of tax | $40731 | $26356 | $72996 | $38972 |

---

See accompanying notes to consolidated condensed financial statements.

------

**TTM TECHNOLOGIES, INC.**

**Consolidated Condensed Statements of Stockholders' Equity**

**For the Two Quarters Ended June 30, 2025 and July 1, 2024**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | **Treasury Stock** | **Treasury Stock** | **Additional<br>Paid-In** | **Retained** | **Accumulated<br>Other<br>Comprehensive** | **Total<br>Stockholders'** |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Capital** | **Earnings** | **Loss** | **Equity** |
|  | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| *Balance, December 30, 2024* | 113161 | $113 | (11164) | $(157570) | $910741 | $838422 | $(27882) | $1563824 |
| &nbsp;&nbsp;Net income |  |  |  |  |  | 32178 |  | 32178 |
| &nbsp;&nbsp;Other comprehensive income |  |  |  |  |  |  | 87 | 87 |
| &nbsp;&nbsp;Issuance of common stock for<br> performance-based<br> restricted stock units | 305 |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Issuance of common stock for<br> restricted stock units | 20 |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Repurchases of common stock |  |  | (700) | (17875) |  |  |  | (17875) |
| &nbsp;&nbsp;Stock-based compensation |  |  |  |  | 8787 |  |  | 8787 |
| *Balance, March 31, 2025* | 113486 | $113 | (11864) | $(175445) | $919528 | $870600 | $(27795) | $1587001 |
| &nbsp;&nbsp;Net income |  |  |  |  |  | 41530 |  | 41530 |
| &nbsp;&nbsp;Other comprehensive loss |  |  |  |  |  |  | (799) | (799) |
| &nbsp;&nbsp;Issuance of common stock for<br> restricted stock units | 1687 | 2 |  |  | (2) |  |  |  |
| &nbsp;&nbsp;Stock-based compensation |  |  |  |  | 9188 |  |  | 9188 |
| *Balance, June 30, 2025* | 115173 | $115 | (11864) | $(175445) | $928714 | $912130 | $(28594) | $1636920 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | **Treasury Stock** | **Treasury Stock** | **Additional<br>Paid-In** | **Retained** | **Accumulated<br>Other<br>Comprehensive** | **Total<br>Stockholders'** |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Capital** | **Earnings** | **Loss** | **Equity** |
|  | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| *Balance, January 1, 2024* | 111282 | $111 | (9174) | $(123091) | $880963 | $782123 | $(29067) | $1511039 |
| &nbsp;&nbsp;Net income |  |  |  |  |  | 10466 |  | 10466 |
| &nbsp;&nbsp;Other comprehensive income |  |  |  |  |  |  | 2150 | 2150 |
| &nbsp;&nbsp;Issuance of common stock for<br> performance-based<br> restricted stock units | 227 | 1 |  |  | (1) |  |  |  |
| &nbsp;&nbsp;Issuance of common stock for<br> restricted stock units | 41 |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Repurchases of common stock |  |  | (600) | (9334) |  |  |  | (9334) |
| &nbsp;&nbsp;Stock-based compensation |  |  |  |  | 6787 |  |  | 6787 |
| *Balance, April 1, 2024* | 111550 | $112 | (9774) | $(132425) | $887749 | $792589 | $(26917) | $1521108 |
| &nbsp;&nbsp;Net income |  |  |  |  |  | 26352 |  | 26352 |
| &nbsp;&nbsp;Other comprehensive income |  |  |  |  |  |  | 4 | 4 |
| &nbsp;&nbsp;Issuance of common stock<br> for restricted stock units | 1559 | 1 |  |  | (1) |  |  |  |
| &nbsp;&nbsp;Repurchases of common stock |  |  | (1390) | (25145) |  |  |  | (25145) |
| &nbsp;&nbsp;Stock-based compensation |  |  |  |  | 6580 |  |  | 6580 |
| *Balance, July 1, 2024* | 113109 | $113 | (11164) | $(157570) | $894328 | $818941 | $(26913) | $1528899 |

---

See accompanying notes to consolidated condensed financial statements.

------

**TTM TECHNOLOGIES, INC.** 

**Consolidated Condensed Statements of Cash Flows** 

**For the Two Quarters Ended June 30, 2025 and July 1, 2024**

---

| | | |
|:---|:---|:---|
|  | **For the Two Quarters Ended** | **For the Two Quarters Ended** |
|  | **June 30, 2025** | **July 1, 2024** |
|  | **(Unaudited)** | **(Unaudited)** |
|  | **(In thousands)** | **(In thousands)** |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $73708 | $36818 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation of property, plant, and equipment | 54555 | 50879 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of definite-lived intangible assets | 18448 | 26356 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt discount and issuance costs | 1067 | 1024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 1389 | (209) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 17975 | 13367 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 7318 | (9193) |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | (46741) | 12843 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contract assets | (43591) | (48070) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (25354) | (3831) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (7876) | (11031) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 47458 | 24198 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contract liabilities | (8785) | 2274 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued salaries, wages, and benefits | (6232) | (9015) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | 3810 | (660) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 87149 | 85750 |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net purchases of property, plant, and equipment and other assets | (123726) | (88811) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of property, plant, and equipment and other assets | 272 | 29560 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of Shanghai E-MS (SH E-MS) property |  | 6737 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (123454) | (52514) |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Repurchases of common stock | (17875) | (34479) |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayment of long-term debt borrowings | (1895) | (2625) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | (19770) | (37104) |
| Effect of foreign currency exchange rates on cash and cash equivalents | 110 | (93) |
| Net decrease in cash and cash equivalents | (55965) | (3961) |
| Cash and cash equivalents at beginning of period | 503932 | 450208 |
| Cash and cash equivalents at end of period | $447967 | $446247 |
| Supplemental cash flow information: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid, net for interest | $23575 | $27048 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid, net for income taxes | 15423 | 11475 |
| Supplemental disclosure of non-cash investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant, and equipment recorded in accounts payable and other current liabilities | $59126 | $75271 |

---

See accompanying notes to consolidated condensed financial statements.

------

**TTM TECHNOLOGIES, INC.**

**Notes to Consolidated Condensed Financial Statements** 

**(Unaudited)** 

**(Dollars and shares in thousands, except per share data)** 

**(1) Nature of Operations and Basis of Presentation**

TTM Technologies, Inc. (the Company or TTM) is a leading global manufacturer of technology solutions including mission systems, radio frequency (RF) components, RF microwave/microelectronic assemblies, and quick-turn and technologically advanced printed circuit boards (PCB). The Company provides time-to-market and volume production of advanced technology products and offers a one-stop design, engineering, and manufacturing solution to customers. This solution allows the Company to align technology developments with the diverse needs of the Company's customers and to enable them to reduce the time required to develop new products and bring them to market.

The Company serves a diversified customer base in various markets throughout the world, including aerospace and defense, data center computing, automotive, medical, industrial, and instrumentation, and networking. The Company's customers include original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, original design manufacturers (ODMs), distributors, and government agencies (both domestic and allied foreign governments).

The accompanying unaudited consolidated condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been condensed or omitted pursuant to such rules and regulations. These consolidated condensed financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's most recent Annual Report on Form 10-K. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company's consolidated condensed financial statements and accompanying notes. Due, in part, to the conflicts between Russia and Ukraine, as well as other global regions and the imposition of, or changes to, tariffs by the United States as well as retaliatory tariffs or measures by other countries, the global economy and financial markets have been volatile in recent periods. As such, the Company has considered information available to it as of the date of issuance of these financial statements and is not aware of any specific events or circumstances that would require an update to its estimates or judgments, or a revision to the carrying value of its assets or liabilities. The actual results the Company experienced may differ materially and adversely from its estimates. The Company uses a 52/53 week fiscal calendar with the fourth quarter ending on the Monday nearest December 31.

***Recently Issued Accounting Standards Not Yet Adopted***

In July 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2025-05, *Measurement of Credit Losses for Accounts Receivable and Contract Assets*, which provides a practical expedient to measure credit losses on accounts receivable and contract assets. The ASU is effective for annual periods beginning after December 15, 2025, and interim periods within those annual reporting periods. Early adoption is permitted. The Company is currently evaluating the timing of the adoption and the impact of this ASU on its consolidated financial statements and related disclosures.

In November 2024, the FASB issued ASU 2024-03, *Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses*, which requires disclosure in the notes to the financial statements of specified information about certain costs and expenses. In January 2025, the FASB issued ASU 2025-01, *Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date*, which amends the effective date of ASU 2024-03 to clarify that all public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption of ASU 2024-03 is permitted. ASU 2024-03 should be applied either prospectively to financial statements issued for reporting periods after the effective date or retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the new guidance to determine the impact it may have on its consolidated financial statements and related disclosures, but expects additional disclosures upon adoption.

In December 2023, the FASB issued ASU 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures*, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. The update will be effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements not yet issued or made available for issuance. The Company will adopt ASU 2023-09 in its 2025 fiscal year Form 10-K. This ASU will impact only the Company's disclosures with no impacts to the results of operations, cash flows, and financial condition.

------

**(2) Share Repurchase Program**

On May 8, 2025, the Company's Board of Directors authorized a new share repurchase program (2025 Repurchase Program), under which the Company may repurchase up to $100,000 in value of the Company's outstanding shares of common stock from time to time through May 7, 2027. The Company's previous two-year repurchase program expired on May 3, 2025. The Company may repurchase shares through open market purchases, privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended (Exchange Act), which sets certain restrictions on the method, timing, price, and volume of open market stock repurchases. In addition, the Company adopted one trading plan in accordance with Rule 10b5-1 of the Exchange Act to facilitate certain purchases that may be effected under the share repurchase program. The timing, manner, price, and amount of any repurchases will be determined at the Company's discretion, and the share repurchase program may be suspended, terminated, or modified at any time for any reason. The repurchase program does not obligate the Company to acquire any specific number of shares.

During the quarter ended June 30, 2025, the Company did not repurchase any shares. During the two quarters ended June 30, 2025, the Company repurchased 700 shares of common stock for a total cost of $17,875 (including commissions) under the Company's previous repurchase program. As of June 30, 2025, the remaining amount in value available to be repurchased under the 2025 Repurchase Program was $100,000.

**(3) Significant Customers and Concentration of Credit Risk** 

Financial instruments that are potentially subject to concentrations of credit risk are primarily cash and cash equivalents and accounts receivable.

The Company had cash and cash equivalents held by its foreign subsidiaries of $137,730 and $207,909 as of June 30, 2025 and December 30, 2024, respectively. The Company maintains its cash and cash equivalents with major financial institutions and such balances exceed Federal Deposit Insurance Corporation insurance limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk on cash and cash equivalents.

In the normal course of business, the Company extends credit to its customers. Some customers to whom the Company extends credit are located outside the United States. The Company performs ongoing credit evaluations of customers, does not require collateral, and considers the credit risk profile of the entity from which the receivable is due in further evaluating collection risk. As of June 30, 2025, one customer accounted for 11% of the Company's accounts receivable. There were no customers that accounted for 10% or more of the Company's accounts receivable as of December 30, 2024.

The Company's customers include both OEMs and EMS companies. The Company's OEM customers often direct a significant portion of their purchases through EMS companies. While the Company's customers include both OEM and EMS providers, the Company measures customer concentration based on OEM companies, as they are the ultimate end customers.

For the quarter and two quarters ended June 30, 2025, one customer accounted for approximately 12% of the Company's net sales. For the quarter and two quarters ended July 1, 2024, one customer accounted for approximately 11% of the Company's net sales.

------

**(4) Revenues**

As of June 30, 2025, the aggregate amount of the transaction price allocated to remaining performance obligations for long-term contracts was $375,733. The Company expects to recognize revenue on approximately 59% of the remaining performance obligations for the Company's long-term contracts over the next 12 months with the remaining amount expected to be recognized thereafter.

For contracts in which anticipated total costs exceed the total expected revenue, an estimated loss is recognized in the period when identifiable. A provision for the entire amount of the estimated loss is recorded on a cumulative basis. The estimated remaining costs to complete for loss contracts as of June 30, 2025 and December 30, 2024 were $32,685 and $36,976, respectively.

Revenue recognized for the two quarters ended June 30, 2025 from amounts recorded as contract liabilities as of December 30, 2024 was $54,970. Revenue recognized for the two quarters ended July 1, 2024 from amounts recorded as contract liabilities as of January 1, 2024 was $28,205.

Revenue from products and services transferred to customers over time and at a point in time accounted for 97% and 3%, respectively, of the Company's revenue for the quarter and two quarters ended June 30, 2025, and 96% and 4%, respectively, of the Company's revenue for the quarter and two quarters ended July 1, 2024.

Disaggregated revenue by principal end markets within reportable segments was as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **For the Quarter Ended** | **For the Quarter Ended** | **For the Quarter Ended** | **For the Quarter Ended** | **For the Quarter Ended** | **For the Quarter Ended** | **For the Quarter Ended** | **For the Quarter Ended** |
|  | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **July 1, 2024** | **July 1, 2024** | **July 1, 2024** | **July 1, 2024** |
|  | **Aerospace and Defense (A&D)** | **Commercial** | **RF and Specialty Components (RF&S Components)** | **Total** | **A&D** | **Commercial** | **RF&S Components** | **Total** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| **End Markets** <sup>(1)</sup>**:** |  |  |  |  |  |  |  |  |
| Aerospace and Defense | $325092 | $— | $— | $325092 | $273038 | $— | $— | $273038 |
| Automotive |  | 81424 |  | 81424 |  | 82635 |  | 82635 |
| Data Center Computing |  | 148222 | 279 | 148501 |  | 123956 | 63 | 124019 |
| Medical/Industrial/Instrumentation |  | 110571 | 1009 | 111580 |  | 86349 | 722 | 87071 |
| Networking |  | 55264 | 8760 | 64024 |  | 30129 | 8245 | 38374 |
| Total | $325092 | $395481 | $10048 | $730621 | $273038 | $323069 | $9030 | $605137 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **For the Two Quarters Ended** | **For the Two Quarters Ended** | **For the Two Quarters Ended** | **For the Two Quarters Ended** | **For the Two Quarters Ended** | **For the Two Quarters Ended** | **For the Two Quarters Ended** | **For the Two Quarters Ended** |
|  | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **July 1, 2024** | **July 1, 2024** | **July 1, 2024** | **July 1, 2024** |
|  | **A&D** | **Commercial** | **RF&S Components** | **Total** | **A&D** | **Commercial** | **RF&S Components** | **Total** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| **End Markets** <sup>(1)</sup>**:** |  |  |  |  |  |  |  |  |
| Aerospace and Defense | $632510 | $— | $— | $632510 | $551304 | $— | $— | $551304 |
| Automotive |  | 152778 |  | 152778 |  | 152908 |  | 152908 |
| Data Center Computing |  | 284989 | 946 | 285935 |  | 237913 | 122 | 238035 |
| Medical/Industrial/Instrumentation |  | 192108 | 1918 | 194026 |  | 161564 | 1456 | 163020 |
| Networking |  | 98036 | 16004 | 114040 |  | 54259 | 15724 | 69983 |
| Total | $632510 | $727911 | $18868 | $1379289 | $551304 | $606644 | $17302 | $1175250 |

---

------

(1)The end market revenue for the A&D and Commercial reportable segments prior to the quarter ended June 30, 2025 has been recast to reflect certain adjustments to allocations resulting from the segment reorganization. The end market revenue excludes intersegment sales totaling $2,650 and $5,650 for the quarter and two quarters ended June 30, 2025, respectively, and $1,708 and $3,489 for the quarter and two quarters ended July 1, 2024, respectively. See Note 10, *Segment Information*, for further information.

------

**(5) Composition of Certain Consolidated Condensed Financial Statement Captions**

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **June 30, 2025** | **December 30, 2024** |
|  | **(In thousands)** | **(In thousands)** |
| Inventories: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Raw materials | $193032 | $178066 |
| &nbsp;&nbsp;&nbsp;&nbsp;Work-in-process | 51611 | 45580 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finished goods | 5696 | 1339 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | $250339 | $224985 |
| Property, plant, and equipment, net: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Land and land use rights | $68098 | $69788 |
| &nbsp;&nbsp;&nbsp;&nbsp;Buildings and improvements | 526374 | 515773 |
| &nbsp;&nbsp;&nbsp;&nbsp;Machinery and equipment | 1155847 | 1116658 |
| &nbsp;&nbsp;&nbsp;&nbsp;Furniture and fixtures and other | 11418 | 11115 |
| &nbsp;&nbsp;&nbsp;&nbsp;Construction-in-progress | 116126 | 75502 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property, plant, and equipment, gross | 1877863 | 1788836 |
| Less: Accumulated depreciation | (958644) | (918879) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property, plant, and equipment, net | $919219 | $869957 |
| Other current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | $13185 | $15919 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales return and allowances | 12256 | 10777 |
| &nbsp;&nbsp;&nbsp;&nbsp;Warranty | 11412 | 7685 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued facility operating costs | 10857 | 8925 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest | 8569 | 9054 |
| &nbsp;&nbsp;&nbsp;&nbsp;Housing fund | 8344 | 7927 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases | 8296 | 7556 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued professional fees | 3624 | 3606 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 35295 | 48525 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | $111838 | $119974 |
| Other long-term liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | $42756 | $41362 |
| &nbsp;&nbsp;&nbsp;&nbsp;Customer deposits | 28390 | 28390 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance leases | 16183 | 11985 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 26630 | 26011 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other long-term liabilities | $113959 | $107748 |

---

------

**(6) Goodwill**

In connection with the Company's assessment of its operating segments, effective during the quarter ended June 30, 2025, the Company determined that its operating segments were also its reporting units and reallocated its PCB goodwill between A&D and Commercial based on the estimated relative fair values of the reporting units. In addition, management performed a goodwill impairment assessment for each segment and concluded no impairment indicators as of June 30, 2025.

Goodwill by reportable segment was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **A&D** | **Commercial** | **RF&S Components** | **Total** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| As of June 30, 2025 and December 30, 2024 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | $256199 | $382636 | $177200 | $816035 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated impairment losses |  |  | (145900) | (145900) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Carrying amount | $256199 | $382636 | $31300 | $670135 |

---

**(7) Definite-lived Intangibles**

The components of definite-lived intangibles were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Gross<br>Amount** | **Accumulated<br>Amortization** | **Net<br>Carrying<br>Amount** | **Weighted<br>Average<br>Amortization<br>Period** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In years)** |
| As of June 30, 2025 |  |  |  |  |
| Customer relationships | $323500 | $(175487) | $148013 | 11.8 |
| Technology | 66650 | (41292) | 25358 | 8.2 |
| Total | $390150 | $(216779) | $173371 |  |
| As of December 30, 2024 |  |  |  |  |
| Customer relationships | $323500 | $(161710) | $161790 | 11.8 |
| Technology | 66650 | (36621) | 30029 | 8.2 |
| Total | $390150 | $(198331) | $191819 |  |

---

Definite-lived intangibles are amortized using the straight-line method of amortization over the useful life. Amortization expense was $9,224 and $18,448 for the quarter and two quarters ended June 30, 2025, respectively, and $12,591 and $26,356 for the quarter and two quarters ended July 1, 2024, respectively. For the quarters ended June 30, 2025 and July 1, 2024, $2,336 and $2,335, respectively, of amortization expense was included in cost of goods sold. For both the two quarters ended June 30, 2025 and July 1, 2024, $4,671 of amortization expense was included in cost of goods sold.

Estimated aggregate amortization for definite-lived intangible assets for the next five years and thereafter is as follows:

---

| | |
|:---|:---|
|  | **(In thousands)** |
| Remaining 2025 | $18449 |
| 2026 | 36897 |
| 2027 | 34543 |
| 2028 | 30997 |
| 2029 | 22355 |
| Thereafter | 30130 |
| Total | $173371 |

---

------

**(8) Long-term Debt and Letters of Credit** 

Long-term debt was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of** | **As of** | **As of** | **As of** |
|  | **June 30, 2025** | **June 30, 2025** | **December 30, 2024** | **December 30, 2024** |
|  | **Interest Rate** | **Principal<br>Outstanding** | **Interest Rate** | **Principal<br>Outstanding** |
|  | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** |
| Senior Notes due March 2029 | 4.00% | $500000 | 4.00% | $500000 |
| Term Loan due May 2030 | 6.57 | 343901 | 6.59 | 345634 |
| Asia ABL Revolving Loan due June 2028 | 5.62 | 80000 | 5.64 | 80000 |
| Other | 5.99 | 2149 | 5.99 | 2311 |
| &nbsp;&nbsp;Total debt |  | 926050 |  | 927945 |
| Less: Unamortized debt issuance costs |  | (6292) |  | (6951) |
| Less: Unamortized debt discount |  | (2614) |  | (2840) |
| &nbsp;&nbsp;Subtotal |  | 917144 |  | 918154 |
| Less: Current maturities |  | (3805) |  | (3795) |
| &nbsp;&nbsp;Long-term debt, less current maturities |  | $913339 |  | $914359 |

---

***Debt Covenants***

Borrowings under the Senior Notes due 2029 and Term Loan Facility due 2030 (Term Loan Facility) are subject to certain affirmative and negative covenants, including limitations on indebtedness, corporate transactions, investments, dispositions, and restricted payments.

Under the occurrence of certain events, the U.S. Asset-Based Lending Credit Agreement (U.S. ABL) and Asia Asset-Based Lending Credit Agreement (Asia ABL) (collectively, the ABL Revolving Loans) are subject to various financial covenants, including leverage and fixed charge coverage ratios.

***Debt Issuance Costs and Debt Discount***

Remaining unamortized debt issuance costs and debt discount were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **As of** | **As of** | **As of** | **As of** | **As of** | **As of** |
|  | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **December 30, 2024** | **December 30, 2024** | **December 30, 2024** |
|  | **Debt<br>Issuance Costs** | **Debt<br>Discount** | **Effective<br>Interest Rate** | **Debt<br>Issuance Costs** | **Debt<br>Discount** | **Effective<br>Interest Rate** |
|  | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** |
| Senior Notes due March 2029 | $2989 | $— | 4.18% | $3362 | $— | 4.18% |
| Term Loan due May 2030 | 3303 | 2614 | 8.01 | 3589 | 2840 | 8.01 |
| Total | $6292 | $2614 |  | $6951 | $2840 |  |

---

The above debt issuance costs and debt discount are recorded as a reduction of the debt and are amortized into interest expense using an effective interest rate over the duration of the debt.

Remaining unamortized debt issuance costs for the ABL Revolving Loans of $1,057 and $1,239 as of June 30, 2025 and December 30, 2024, respectively, are included in deposits and other non-current assets and are amortized to interest expense over the duration of the ABL Revolving Loans using the straight-line method of amortization.

As of June 30, 2025, the remaining weighted average amortization period for all unamortized debt issuance costs and debt discount was 4.3 years.

------

**(9) Income Taxes** 

The Company's effective tax rate is impacted by the mix of foreign and U.S. income, tax rates in China and Hong Kong, the U.S. federal income tax rate, apportioned state income tax rates, the generation of credits, and deductions available to the Company as well as changes in valuation allowances and certain non-deductible items. No tax benefit was recorded on the losses incurred in certain foreign jurisdictions as a result of corresponding increases in the valuation allowances in these jurisdictions.

During the quarter and two quarters ended June 30, 2025, the Company's effective tax rate was impacted by a net discrete benefit of $4,166 and $3,284, respectively. This was primarily related to income tax benefits from the deduction of stock-based compensation and the release of uncertain tax positions due to the expiration of the statute of limitations in certain foreign jurisdiction, partially offset by accruals for potential assessments in various jurisdictions and the finalization of China and Canada corporate income tax returns.

The Company has various foreign subsidiaries formed or acquired to conduct or support its business outside the U.S. The Company expects its earnings attributable to most foreign subsidiaries may be repatriated back to the U.S. and so a deferred tax liability has been recorded for foreign withholding taxes and the estimated federal/state tax impact on any repatriation. For those other companies with earnings currently being reinvested outside of the U.S., no deferred tax liability on undistributed earnings has been recorded.

***One Big Beautiful Bill Act (OBBBA)***

On July 4, 2025, the OBBBA was enacted, introducing amendments to U.S. tax laws with various effective dates from 2025 to 2027. The OBBBA includes provisions such as the permanent extension of certain provisions of the Tax Cuts and Jobs Act that were set to expire at the end of 2025 and modifications to the international tax framework. Topic 740 requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which the legislation is enacted. Therefore, the Company's tax provisions for the quarter and two quarters ended June 30, 2025, do not incorporate the effects of these tax law changes. The Company is in the process of evaluating and estimating the impact of the OBBBA on its consolidated condensed financial statements and will complete its assessment during the third quarter of 2025.

------

**(10) Segment Information** 

During the quarter ended June 30, 2025, in connection with the Company's change in organizational structure to enhance clarity in sector performance, accountability, and operating costs, the Company's management finalized its assessment of the Company's operating segments and concluded that the Company now has three reportable segments: A&D, Commercial, and RF&S Components. In prior periods, the Company had two reportable segments: PCB and RF&S Components. As a result, certain prior period amounts have been reclassified to conform with this new presentation.

The reportable segments shown below are the Company's segments for which separate financial information is available and upon which operating results are evaluated by the chief operating decision maker (CODM), who is the President and Chief Executive Officer, to assess performance and to allocate resources. The CODM uses segment operating income to allocate resources such as employees and capital resources for each segment during the Company's annual budgeting and forecasting process. Total sales and operating profit by segment include intersegment sales which are generally recorded at cost-plus a specified fee or at a negotiated fixed price. Separate segment asset measures are not used as a basis for the CODM to evaluate the performance of or to allocate resources to the segments.

The A&D reportable segment consists of PCBs, value-added assemblies, microelectronics, RF/microwave components and assemblies, and integrated mission systems. These highly engineered electronics products include the manufacture and test of customer-supplied designs as well as long-term contracts to design, develop, manufacture, and test new products. The products in the A&D reportable segment support surveillance, intelligence, communications, and other critical missions for customers in the aerospace and defense industry. The Commercial reportable segment consists of PCBs using customer-supplied engineering and design plans supporting customers in the automotive, medical, industrial, and instrumentation, networking, and data center computing end markets. The RF&S Components reportable segment consists of TTM designed RF components for commercial customers in the telecommunications, industrial and instrumentation markets, as well as commercial off-the-shelf (COTS) components for certain aerospace and defense customers.

Reconciliations of net sales and segment operating income were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **For the Quarter Ended June 30, 2025** | **For the Quarter Ended June 30, 2025** | **For the Quarter Ended June 30, 2025** | **For the Quarter Ended June 30, 2025** | **For the Quarter Ended June 30, 2025** |
|  | **A&D** | **Commercial** | **RF&S Components** | **Eliminations** | **Total** |
|  | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** |
| Net sales | $325092 | $395481 | $10048 | $— | $730621 |
| Intersegment sales | 2477 | 143 | 30 | (2650) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Segment sales | $327569 | $395624 | $10078 | $(2650) | $730621 |
|  | **Net Sales** | **Cost of Goods Sold** | **Operating Expenses** | **Operating Income** | **Operating Margin** |
| A&D | $327569 | $(251046) | $(31241) | $45282 | 13.8% |
| Commercial | 395624 | (317652) | (17903) | 60069 | 15.2 |
| RF&S Components | 10078 | (4855) | (2360) | 2863 | 28.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total segment | 733271 | (573553) | (51504) | 108214 | 14.8 |
| Eliminations | (2650) |  |  |  |  |
| Unallocated amounts: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring |  |  |  | (1408) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation |  |  |  | (9188) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other corporate expenses |  |  |  | (26625) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of definite-lived intangibles <sup>(1)</sup> |  |  |  | (9224) |  |
| Consolidated | $730621 |  |  | 61769 | 8.5% |
| Interest expense |  |  |  | (11095) |  |
| Other, net |  |  |  | (5149) |  |
| Income before income taxes |  |  |  | $45525 |  |

---

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **For the Quarter Ended July 1, 2024** | **For the Quarter Ended July 1, 2024** | **For the Quarter Ended July 1, 2024** | **For the Quarter Ended July 1, 2024** | **For the Quarter Ended July 1, 2024** |
|  | **A&D** | **Commercial** | **RF&S Components** | **Eliminations** | **Total** |
|  | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** |
| Net sales | $273038 | $323069 | $9030 | $— | $605137 |
| Intersegment sales | 1469 | 186 | 53 | (1708) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Segment sales | $274507 | $323255 | $9083 | $(1708) | $605137 |
|  | **Net Sales** | **Cost of Goods Sold** | **Operating Expenses** | **Operating Income** | **Operating Margin** |
| A&D | $274507 | $(220647) | $(28360) | $25500 | 9.3% |
| Commercial | 323255 | (256244) | (17341) | 49670 | 15.4 |
| RF&S Components | 9083 | (4586) | (2445) | 2052 | 22.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total segment | 606845 | (481477) | (48146) | 77222 | 12.7 |
| Eliminations | (1708) |  |  |  |  |
| Unallocated amounts: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring |  |  |  | (1036) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of property, plant, and equipment |  |  |  | 14420 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related and other charges |  |  |  | (10184) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation |  |  |  | (6580) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other corporate expenses |  |  |  | (22265) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of definite-lived intangibles <sup>(1)</sup> |  |  |  | (12591) |  |
| Consolidated | $605137 |  |  | 38986 | 6.4% |
| Interest expense |  |  |  | (12219) |  |
| Other, net |  |  |  | 3765 |  |
| Income before income taxes |  |  |  | $30532 |  |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **For the Two Quarters Ended June 30, 2025** | **For the Two Quarters Ended June 30, 2025** | **For the Two Quarters Ended June 30, 2025** | **For the Two Quarters Ended June 30, 2025** | **For the Two Quarters Ended June 30, 2025** |
|  | **A&D** | **Commercial** | **RF&S Components** | **Eliminations** | **Total** |
|  | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** |
| Net sales | $632510 | $727911 | $18868 | $— | $1379289 |
| Intersegment sales | 5202 | 418 | 30 | (5650) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Segment sales | $637712 | $728329 | $18898 | $(5650) | $1379289 |
|  | **Net Sales** | **Cost of Goods Sold** | **Operating Expenses** | **Operating Income** | **Operating Margin** |
| A&D | $637712 | $(489975) | $(61678) | $86059 | 13.5% |
| Commercial | 728329 | (586737) | (37874) | 103718 | 14.2 |
| RF&S Components | 18898 | (9633) | (4810) | 4455 | 23.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total segment | 1384939 | (1086345) | (104362) | 194232 | 14.0 |
| Eliminations | (5650) |  |  |  |  |
| Unallocated amounts: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring |  |  |  | (2122) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation |  |  |  | (17975) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other corporate expenses |  |  |  | (43658) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of definite-lived intangibles <sup>(1)</sup> |  |  |  | (18448) |  |
| Consolidated | $1379289 |  |  | 112029 | 8.1% |
| Interest expense |  |  |  | (22559) |  |
| Other, net |  |  |  | (2954) |  |
| Income before income taxes |  |  |  | $86516 |  |

---

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **For the Two Quarters Ended July 1, 2024** | **For the Two Quarters Ended July 1, 2024** | **For the Two Quarters Ended July 1, 2024** | **For the Two Quarters Ended July 1, 2024** | **For the Two Quarters Ended July 1, 2024** |
|  | **A&D** | **Commercial** | **RF&S Components** | **Eliminations** | **Total** |
|  | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** |
| Net sales | $551304 | $606644 | $17302 | $— | $1175250 |
| Intersegment sales | 2961 | 414 | 114 | (3489) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Segment sales | $554265 | $607058 | $17416 | $(3489) | $1175250 |
|  | **Net Sales** | **Cost of Goods Sold** | **Operating Expenses** | **Operating Income** | **Operating Margin** |
| A&D | $554265 | $(437347) | $(56945) | $59973 | 10.8% |
| Commercial | 607058 | (493084) | (34221) | 79753 | 13.1 |
| RF&S Components | 17416 | (8990) | (4713) | 3713 | 21.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total segment | 1178739 | (939421) | (95879) | 143439 | 12.2 |
| Eliminations | (3489) |  |  |  |  |
| Unallocated amounts: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring |  |  |  | (4974) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of property, plant, and equipment |  |  |  | 14420 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related and other charges |  |  |  | (10072) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation |  |  |  | (13367) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other corporate expenses |  |  |  | (47037) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of definite-lived intangibles <sup>(1)</sup> |  |  |  | (26356) |  |
| Consolidated | $1175250 |  |  | 56053 | 4.8% |
| Interest expense |  |  |  | (24543) |  |
| Other, net |  |  |  | 13091 |  |
| Income before income taxes |  |  |  | $44601 |  |

---

------

(1)Amortization of definite-lived intangibles relates to the A&D, Commercial, and RF&S Components reportable segments, but is not reviewed separately by the CODM. For the quarters ended June 30, 2025 and July 1, 2024, amortization expense of $2,336 and $2,335, respectively, is included in cost of goods sold for the A&D reportable segment. For both the two quarters ended June 30, 2025 and July 1, 2024, amortization expense of $4,671 is included in cost of goods sold for the A&D reportable segment.

Depreciation expense by reportable segment was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Quarter Ended** | **For the Quarter Ended** | **For the Two Quarters Ended** | **For the Two Quarters Ended** |
|  | **June 30, 2025** | **July 1, 2024** | **June 30, 2025** | **July 1, 2024** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| A&D | $8942 | $9490 | $17733 | $19014 |
| Commercial | 16956 | 14651 | 33345 | 27964 |
| RF&S Components | 443 | 419 | 866 | 886 |
| &nbsp;&nbsp;&nbsp;&nbsp;Segment total | 26341 | 24560 | 51944 | 47864 |
| Corporate | 1351 | 1623 | 2611 | 3015 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $27692 | $26183 | $54555 | $50879 |

---

The Company markets and sells its products in approximately 50 countries. For the quarter and two quarters ended June 30, 2025, the Company did not conduct business in any country other than the United States in which its net sales in that country exceeded 10% of the Company's total net sales. For the quarter and two quarters ended July 1, 2024, net sales in Taiwan also exceeded 10% of the Company's total net sales. Net sales are attributed to countries by the invoiced location and were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Quarter Ended** | **For the Quarter Ended** | **For the Two Quarters Ended** | **For the Two Quarters Ended** |
|  | **June 30, 2025** | **July 1, 2024** | **June 30, 2025** | **July 1, 2024** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| United States | $381619 | $308774 | $739427 | $609733 |
| Taiwan | 50856 | 73931 | 105012 | 142855 |
| Other | 298146 | 222432 | 534850 | 422662 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net sales | $730621 | $605137 | $1379289 | $1175250 |

---

------

**(11) Accumulated Other Comprehensive Loss**

The components of accumulated other comprehensive loss, net of tax, were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Foreign<br>Currency<br>Translation** | **Pension<br>Obligation** | **Cash Flow<br>Hedges** | **Total** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| Balance as of December 30, 2024 | $(33757) | $3612 | $2263 | $(27882) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) <br> before reclassifications | 159 |  | (1774) | (1615) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from accumulated <br> other comprehensive loss |  | 1174 | (271) | 903 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net year to date other comprehensive <br> income (loss) | 159 | 1174 | (2045) | (712) |
| Balance as of June 30, 2025 | $(33598) | $4786 | $218 | $(28594) |

---

**(12) Earnings Per Share** 

The reconciliation of the numerator and denominator used to calculate basic earnings per share and diluted earnings per share is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Quarter Ended** | **For the Quarter Ended** | **For the Two Quarters Ended** | **For the Two Quarters Ended** |
|  | **June 30, 2025** | **July 1, 2024** | **June 30, 2025** | **July 1, 2024** |
|  | **(In thousands, except per share amounts)** | **(In thousands, except per share amounts)** | **(In thousands, except per share amounts)** | **(In thousands, except per share amounts)** |
| Net income | $41530 | $26352 | $73708 | $36818 |
| Basic weighted average shares | 101857 | 101234 | 101861 | 101593 |
| Dilutive effect of performance-based<br>&nbsp;&nbsp;&nbsp;&nbsp;restricted stock units (PRUs), restricted<br>&nbsp;&nbsp;&nbsp;&nbsp;stock units (RSUs), and stock options | 3016 | 2655 | 2840 | 2400 |
| Diluted shares | 104873 | 103889 | 104701 | 103993 |
| Earnings per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic earnings per share | $0.41 | $0.26 | $0.72 | $0.36 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted earnings per share | 0.40 | 0.25 | 0.70 | 0.35 |

---

PRUs, RSUs, and stock options to purchase 369 and 250 shares of common stock for the quarter and two quarters ended June 30, 2025, respectively, and 330 and 177 shares of common stock for the quarter and two quarters ended July 1, 2024, respectively, were not included in the computation of diluted earnings per share because the impact would be anti-dilutive. The PRUs would have had an anti-dilutive impact because the performance conditions had not been met during the applicable quarter and two quarters. The RSUs and stock options would have had an anti-dilutive impact because the total expected proceeds under the treasury stock method or the options' exercise prices were greater than the average market price of common stock during the applicable quarter and two quarters.

------

**(13) Fair Value Measures** 

The Company measures at fair value its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability.

The carrying amount and estimated fair value of the Company's financial instruments were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of** | **As of** | **As of** | **As of** |
|  | **June 30, 2025** | **June 30, 2025** | **December 30, 2024** | **December 30, 2024** |
|  | **Carrying Amount** | **Fair Value** | **Carrying Amount** | **Fair Value** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| Derivative assets, current | $1524 | $1524 | $1765 | $1765 |
| Derivative assets, non-current |  |  | 1326 | 1326 |
| Derivative liabilities, current |  |  | 667 | 667 |
| Derivative liabilities, non-current | 872 | 872 |  |  |
| Senior Notes due March 2029 | 497011 | 477010 | 496638 | 464325 |
| Term Loan due May 2030 | 337984 | 344761 | 339205 | 346930 |
| ABL Revolving Loans | 80000 | 80000 | 80000 | 80000 |
| Other loan | 2149 | 2149 | 2311 | 2311 |

---

The fair value of the derivative instruments was determined using pricing models developed based on the 1-month Chicago Mercantile Exchange (CME) Term Secured Overnight Financing Rate (SOFR) swap rate and other observable market data, including quoted market prices, as appropriate using Level 2 inputs. The values were adjusted to reflect non-performance risk of both the counterparty and the Company, as necessary.

The fair value of the long-term debt was estimated based on quoted market prices or discounting the debt over its life using current market rates for similar debt as of June 30, 2025 and December 30, 2024, which are considered Level 2 inputs.

As of June 30, 2025 and December 30, 2024, the Company's other financial instruments included cash and cash equivalents, accounts receivable, contract assets, accounts payable, and contract liabilities. The carrying amount of these instruments approximates fair value.

The majority of the Company's non-financial assets and liabilities, which include goodwill, intangible assets, inventories, and property, plant, and equipment, are not required to be carried at fair value on a recurring basis. However, if certain triggering events occur (or as indicated by the annual test in the case of goodwill) such that a non-financial instrument is required to be evaluated for impairment, based upon a comparison of the non-financial instrument's fair value to its carrying value, an impairment is recorded to reduce the carrying value to the fair value, if the carrying value exceeds the fair value.

**(14) Commitments and Contingencies** 

***Legal Matters*** 

The Company is subject to various legal matters, which it considers normal for its business activities. While the Company currently believes that the amount of any reasonably possible loss for known matters would not be material to the Company's financial condition, the outcome of these actions is inherently difficult to predict. In the event of an adverse outcome, the ultimate potential loss could have a material adverse effect on the Company's financial condition or results of operations in a particular period. The Company has accrued amounts for its loss contingencies which are probable and estimable as of June 30, 2025 and December 30, 2024 and included as a component of other current liabilities. However, these amounts are not material to the consolidated condensed financial statements of the Company.

***Supplier Finance Program Obligations*** 

The Company has agreements with financial institutions to facilitate payments to certain suppliers. Liabilities associated with these agreements are recorded in accounts payable on the consolidated condensed balance sheets and amounted to $12,808 and $17,218 as of June 30, 2025 and December 30, 2024, respectively.

------

**Item 2. *Management's Discussion and Analysis of Financial Condition and Results of Operations*** 

**Cautionary Statement Regarding Forward-Looking Statements**

*This Quarterly Report on Form 10-Q (Report) contains forward-looking statements regarding future events or our future financial and operational performance. Forward-looking statements include statements regarding markets for our products; trends in net sales, gross profits, and estimated expense levels; liquidity and anticipated cash needs and availability; and any statement that contains the words "anticipate," "believe," "plan," "forecast," "foresee," "estimate," "project," "expect," "seek," "target," "intend," "goal," and other similar expressions. The forward-looking statements included in this Report reflect our current expectations and beliefs, and we do not undertake publicly to update or revise these statements, even if experience or future changes make it clear that any projected results expressed in this Report or future quarterly reports to stockholders, press releases, or company statements will not be realized. In addition, the inclusion of any statement in this Report does not constitute an admission by us that the events or circumstances described in such statement are material. Furthermore, we wish to caution and advise readers that these statements are based on assumptions that may not materialize and may involve risks and uncertainties, many of which are beyond our control, that could cause actual events or performance to differ materially from those contained or implied in these forward-looking statements. These risks and uncertainties include the risks identified under the heading "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 30, 2024, as updated by our other filings with the Securities and Exchange Commission (SEC), and described elsewhere in this Report. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated condensed financial statements and the related notes and the other financial information included in this Report, as well as the "Management's Discussion and Analysis of Financial Condition and Results of Operations" set forth in our Annual Report on Form 10-K for the fiscal year ended December 30, 2024, filed with the SEC.*

**COMPANY OVERVIEW** 

We are a leading global manufacturer of technology solutions including mission systems, radio frequency (RF) components, RF microwave/microelectronic assemblies, and quick-turn and technologically advanced printed circuit boards (PCB). We focus on providing time-to-market and volume production of advanced technology products and offer a one-stop design, engineering, and manufacturing solution to our customers. This solution allows us to align technology development with the diverse needs of our customers and to enable them to reduce the time required to develop new products and bring them to market. We serve a diversified customer base consisting of approximately 1,400 customers in various markets throughout the world, including aerospace and defense, data center computing, automotive, medical, industrial, and instrumentation, and networking. Our customers include original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, original design manufacturers (ODMs), distributors, and government agencies (both domestic and allied foreign governments).

**RECENT DEVELOPMENTS**

On July 9, 2025, we announced the acquisition of a 750,000-square-foot facility in Eau Claire, Wisconsin, as well as land rights for an additional future manufacturing site in Penang, Malaysia. We believe the Eau Claire, Wisconsin facility comes equipped with the necessary infrastructure to support advanced technology PCB manufacturing and enhances our ability to support future high-volume U.S. production of advanced technology PCBs across key markets, particularly data center computing and networking for generative artificial intelligence (AI) applications. In addition, we acquired land rights for ten acres in Penang to establish a new production site that we anticipate will align with customers' increasing interests in supply chain diversification beyond China. The future Penang facility will be in close proximity to our existing facility and will enable us to deliver cost-competitive, high-quality advanced technology PCB manufacturing to commercial markets such as data center computing, networking, and medical, industrial, and instrumentation. Together, these new investments support our strategy to offer regionally optimized, globally connected manufacturing solutions for our customers.

We previously announced we are in the process of constructing a new advanced technology PCB manufacturing facility in Syracuse, New York. We expect that our new facility will bring advanced technology capability for our domestic high-volume production of ultra-high-density interconnect (HDI) PCBs in support of national security requirements. The external construction of our facility is largely complete and we continue to make progress on the internal fabrication. We have equipment orders in place and, assuming no delays in delivery, expect installation to begin in the third quarter of 2025 with production expected to commence in the second half of 2026.

------

**FINANCIAL OVERVIEW**

Our customers include both OEMs and EMS providers. We sell to OEMs both directly and indirectly through EMS providers. For such indirect sales, we measure customers based on OEM companies as they are the ultimate end customers. Sales to our ten largest customers collectively accounted for 53% and 54% of our net sales for the quarter and two quarters ended June 30, 2025, respectively. Sales to our ten largest customers collectively accounted for 54% of our net sales for both the quarter and two quarters ended July 1, 2024.

The percentage of our net sales attributable to each of the principal end markets we served was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Quarter Ended** | **For the Quarter Ended** | **For the Two Quarters Ended** | **For the Two Quarters Ended** |
|  | **June 30, 2025** | **July 1, 2024** <sup>(1)</sup> | **June 30, 2025** <sup>(1)</sup> | **July 1, 2024** <sup>(1)</sup> |
| **End Markets** <sup>(2)</sup>**:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Aerospace and Defense | 45% | 45% | 47% | 47% |
| &nbsp;&nbsp;&nbsp;&nbsp;Automotive | 11 | 14 | 11 | 13 |
| &nbsp;&nbsp;&nbsp;&nbsp;Data Center Computing | 21 | 21 | 21 | 20 |
| &nbsp;&nbsp;&nbsp;&nbsp;Medical/Industrial/Instrumentation | 15 | 14 | 14 | 14 |
| &nbsp;&nbsp;&nbsp;&nbsp;Networking | 8 | 6 | 7 | 6 |
| Total | 100% | 100% | 100% | 100% |

---

------

(1)The end market revenue prior to the quarter ended June 30, 2025 has been recast to reflect certain adjustments to allocations resulting from the segment reorganization.

(2)Sales to EMS companies are classified by the end markets of their OEM customers.

We derive revenues primarily from the sale of PCBs, engineered systems using customer-supplied engineering and design plans, as well as our long-term contracts related to the design and manufacture of highly sophisticated intelligence, surveillance, and communications solutions, and RF microwave/microelectronics components, assemblies, and subsystems. Orders for products generally correspond to the production schedules of our customers and are supported with firm purchase orders. Our customers have continuous control of the work in progress and finished goods throughout the PCB and engineered systems manufacturing process, as these are built to customer specifications with no alternative use, and there is an enforceable right of payment for work performed to date. As a result, we recognize revenue progressively over time based on the extent of progress towards completion of the performance obligation. We recognize revenue based on a cost method as it best depicts the transfer of control to the customer which takes place as we incur costs. Revenues are recorded proportionally as costs are incurred.

We also manufacture certain components, assemblies, subsystems, and completed systems which service our RF and Specialty Components (RF&S Components) customers and certain aerospace and defense customers. We recognize revenue at a point in time upon transfer of control of the products to our customer. Point in time recognition was determined as our customers do not simultaneously receive or consume the benefits provided by our performance and the asset being manufactured has alternative uses to us.

Net sales consist of gross sales less an allowance for returns, which typically have been approximately 2% of gross sales. We provide our customers a limited right of return for defective PCBs including components, assemblies, and subsystems. We record an estimate for sales returns and allowances at the time of sale based on historical results and anticipated returns.

Cost of goods sold consists of materials, labor, outside services, and overhead expenses incurred in the manufacture and testing of our products. Shipping and handling fees and related freight costs and supplies associated with shipping products are also included as a component of cost of goods sold. Many factors affect our gross margin, including capacity utilization, product mix, production volume, supply chain costs, and yield.

Selling and marketing expenses consist primarily of salaries, labor-related benefits, and commissions paid to our internal sales force, independent sales representatives, and our sales support staff, as well as costs associated with marketing materials and trade shows.

General and administrative costs primarily include the salaries for executive, finance, accounting, information technology, and human resources personnel, as well as expenses for accounting and legal assistance, incentive compensation expense, and gains or losses on the sale or disposal of property, plant, and equipment.

Research and development expenses consist primarily of salaries and labor-related benefits paid to our research and development staff, as well as material costs.

**CRITICAL ACCOUNTING POLICIES AND ESTIMATES** 

Our consolidated condensed financial statements included in this Report have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, net sales and expenses, and related disclosure of contingent assets and liabilities.

------

See Item 7, *Management's Discussion and Analysis of Financial Condition and Results of Operations*, in our Annual Report on Form 10-K for the fiscal year ended December 30, 2024 for further discussion of critical accounting policies and estimates. There have been no material changes to our critical accounting policies and estimates since December 30, 2024.

**CONSOLIDATED OPERATING RESULTS**

Selected financial highlights are presented in the table below:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Quarter Ended** | **For the Quarter Ended** | **For the Two Quarters Ended** | **For the Two Quarters Ended** |
|  | **June 30, 2025** | **July 1, 2024** | **June 30, 2025** | **July 1, 2024** |
|  | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** |
| Net sales | $730621 | $605137 | $1379289 | $1175250 |
| Cost of goods sold | 582512 | 487910 | 1100208 | 954304 |
| Gross profit | 148109 | 117227 | 279081 | 220946 |
| *Gross margin* | *20.3%* | *19.4%* | *20.2%* | *18.8%* |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling and marketing | 21316 | 19798 | 42587 | 40092 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 49719 | 38604 | 93493 | 82274 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 7009 | 8547 | 15073 | 15868 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of definite-lived intangibles | 6888 | 10256 | 13777 | 21685 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges | 1408 | 1036 | 2122 | 4974 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 86340 | 78241 | 167052 | 164893 |
| Operating income | 61769 | 38986 | 112029 | 56053 |
| *Operating margin* | *8.5%* | *6.4%* | *8.1%* | *4.8%* |
| Total other expense, net | (16244) | (8454) | (25513) | (11452) |
| Income tax provision | (3995) | (4180) | (12808) | (7783) |
| Net income | $41530 | $26352 | $73708 | $36818 |

---

*The following discussion and analysis is for the quarter and two quarters ended June 30, 2025, compared to the quarter and two quarters ended July 1, 2024, unless otherwise stated.*

***Net Sales*** 

Total net sales increased $125.5 million, or 20.7%, to $730.6 million for the quarter ended June 30, 2025, from $605.1 million for the quarter ended July 1, 2024. The primary driver of this increase was strong demand in our aerospace and defense, data center computing, and networking end markets, the latter two being driven by generative AI. In addition, our medical, industrial, and instrumentation end market was also stronger as inventories and demand have normalized in this end market.

Total net sales increased $204.0 million, or 17.4%, to $1,379.3 million for the two quarters ended June 30, 2025, from $1,175.3 million for the two quarters ended July 1, 2024. The primary drivers of the increase were as discussed in the paragraph above.

***Gross Profit and Margin Rate***

Gross profit increased $30.9 million to $148.1 million for the quarter ended June 30, 2025, from $117.2 million for the quarter ended July 1, 2024, primarily due to higher sales. Gross margin rate increased to 20.3% for the quarter ended June 30, 2025, from 19.4% for the quarter ended July 1, 2024. This increase was primarily due to improved operational execution, favorable product mix, and increased volume of PCB shipments as compared to the second quarter of 2024.

Gross profit increased $58.1 million to $279.1 million for the two quarters ended June 30, 2025, from $220.9 million for the two quarters ended July 1, 2024, primarily due to higher sales. Gross margin rate increased to 20.2% for the two quarters ended June 30, 2025, from 18.8% for the two quarters ended July 1, 2024. The increase was primarily due to improved operational execution, favorable product mix, and increased volume of PCB shipments as compared to the same period of 2024.

***Operating Expenses***

Operating expenses increased $8.1 million to $86.3 million for the quarter ended June 30, 2025, from $78.2 million for the quarter ended July 1, 2024, primarily due to the absence of gains on the sale of assets primarily related to the sale of two buildings vacated with the closure of our Anaheim and Santa Clara plants of $14.4 million that occurred in the quarter ended July 1, 2024, partially offset by the absence of the write down of our Hong Kong building of $6.1 million that occurred in the quarter ended July 1, 2024. Higher incentive compensation expense also contributed to the increase in operating expenses, partially offset by a decrease in amortization of definite-lived intangibles.

------

Operating expenses increased $2.2 million to $167.1 million for the two quarters ended June 30, 2025, from $164.9 million for the two quarters ended July 1, 2024, primarily due to the absence of gains on the sale of assets primarily related to the sale of two buildings vacated with the closure of our Anaheim and Santa Clara plants of $14.4 million that occurred in the two quarters ended July 1, 2024, partially offset by the absence of the write down of our Hong Kong building of $6.1 million that occurred in the two quarters ended July 1, 2024. In addition, increased stock-based compensation and incentive compensation expense contributed to the higher operating expenses, partially offset by a decrease in amortization of definite-lived intangibles.

***Operating Income and Margin Rate***

Operating income increased $22.8 million to $61.8 million for the quarter ended June 30, 2025, from $39.0 million for the quarter ended July 1, 2024. Operating margin rate increased to 8.5% for the quarter ended June 30, 2025, from 6.4% for the quarter ended July 1, 2024. The primary drivers of these increases are discussed above in the variance explanations for *Gross Profit and Margin Rate* and *Operating Expenses*.

Operating income increased $56.0 million to $112.0 million for the two quarters ended June 30, 2025, from $56.1 million for the two quarters ended July 1, 2024. Operating margin rate increased to 8.1% for the two quarters ended June 30, 2025, from 4.8% for the two quarters ended July 1, 2024. The primary drivers of these increases are discussed above in the variance explanations for *Gross Profit and Margin Rate* and *Operating Expenses*.

***Total Other Expense, Net***

Total other expense, net increased $7.8 million to $16.2 million for the quarter ended June 30, 2025, from $8.5 million for the quarter ended July 1, 2024, primarily as a result of unrealized foreign exchange losses during the quarter ended June 30, 2025. We utilize the Chinese Renminbi (RMB) and Malaysian Ringgit (MYR) at our China and Malaysia facilities, respectively, for employee-related and other costs of running our operations in foreign countries. There was an unrealized loss from foreign exchange of $5.7 million during the quarter ended June 30, 2025, compared to $0.1 million during the quarter ended July 1, 2024. This unrealized loss was related to the translation of our China and Malaysia balance sheets from their local currencies into the U.S. dollar functional currency, which experienced devaluation against the RMB and MYR during the quarter ended June 30, 2025 as compared to the quarter ended July 1, 2024.

Total other expense, net increased $14.1 million to $25.5 million for the two quarters ended June 30, 2025, from $11.5 million for the two quarters ended July 1, 2024, primarily as a result of unrealized foreign exchange losses during the two quarters ended June 30, 2025. There was an $8.0 million unrealized loss from foreign exchange during the two quarters ended June 30, 2025, compared to a $4.2 million unrealized gain from foreign exchange during the two quarters ended July 1, 2024. This unrealized loss was related to the translation of our China and Malaysia balance sheets from their local currencies into the U.S. dollar functional currency, which experienced devaluation against the RMB and MYR during the two quarters ended June 30, 2025 as compared to the two quarters ended July 1, 2024.

***Income Taxes*** 

Income tax expense decreased $0.2 million to $4.0 million for the quarter ended June 30, 2025, from $4.2 million for the quarter ended July 1, 2024, primarily due to an income tax benefit from the deduction of stock-based compensation, partially offset by accruals for potential assessments in various jurisdictions and the finalization of China and Canada corporate income tax returns.

Income tax expense increased $5.0 million to $12.8 million for the two quarters ended June 30, 2025, from $7.8 million for the two quarters ended July 1, 2024, primarily due to an increase in income before income taxes for the two quarters ended June 30, 2025 and accruals for potential assessments in various jurisdictions, partially offset by an income tax benefit from the deduction of stock-based compensation.

On July 4, 2025, the One Big Beautiful Bill Act (OBBBA) was enacted, introducing amendments to U.S. tax laws with various effective dates from 2025 to 2027. The OBBBA includes provisions such as the permanent extension of certain provisions of the Tax Cuts and Jobs Act that were set to expire at the end of 2025 and modifications to the international tax framework. *Income Taxes (Topic 740): Improvements to Income Tax Disclosures* requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which the legislation is enacted. Therefore, our tax provisions for the quarter and two quarters ended June 30, 2025, do not incorporate the effects of these tax law changes. We are in the process of evaluating and estimating the impact of the OBBBA on our consolidated condensed financial statements and will complete our assessment during the third quarter of 2025.

Our effective tax rate is primarily impacted by the mix of foreign and U.S. income, tax rates in China and Hong Kong, the U.S. federal income tax rate, apportioned state income tax rates, the generation of credits and deductions available to us as well as changes in valuation allowances and certain non-deductible items. We had a net deferred income tax liability of $41.8 million and $42.9 million as of June 30, 2025 and July 1, 2024, respectively.

------

**SEGMENT OPERATING RESULTS**

**Basis of Presentation**

During the quarter ended June 30, 2025, in connection with our change in organizational structure to enhance clarity in sector performance, accountability, and operating costs, our management finalized its assessment of our operating segments and concluded that we now have three reportable segments: Aerospace and Defense (A&D), Commercial, and RF&S Components. As a result, certain prior period amounts have been reclassified to conform with this new presentation. See Part I, Item 1, Note 10, *Segment Information*, of the Notes to Consolidated Condensed Financial Statements in this Report for further information.

Selected segment financial highlights, with reconciliations to operating income, are presented in the table below:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Quarter Ended** | **For the Quarter Ended** | **For the Two Quarters Ended** | **For the Two Quarters Ended** |
|  | **June 30, 2025** | **July 1, 2024** | **June 30, 2025** | **July 1, 2024** |
|  | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** | **(In thousands, except margin rates)** |
| Segment sales: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;A&D | $327569 | $274507 | $637712 | $554265 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commercial | 395624 | 323255 | 728329 | 607058 |
| &nbsp;&nbsp;&nbsp;&nbsp;RF&S Components | 10078 | 9083 | 18898 | 17416 |
| Total | $733271 | $606845 | $1384939 | $1178739 |
| Segment operating income: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;A&D | $45282 | $25500 | $86059 | $59973 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commercial | 60069 | 49670 | 103718 | 79753 |
| &nbsp;&nbsp;&nbsp;&nbsp;RF&S Components | 2863 | 2052 | 4455 | 3713 |
| Total | 108214 | 77222 | 194232 | 143439 |
| *Segment operating margin rate:* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;*A&D* | *13.8%* | *9.3%* | *13.5%* | *10.8%* |
| &nbsp;&nbsp;&nbsp;&nbsp;*Commercial* | *15.2%* | *15.4%* | *14.2%* | *13.1%* |
| &nbsp;&nbsp;&nbsp;&nbsp;*RF&S Components* | *28.4%* | *22.6%* | *23.6%* | *21.3%* |
| *Total* | *14.8%* | *12.7%* | *14.0%* | *12.2%* |
| Unallocated amounts: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring | (1408) | (1036) | (2122) | (4974) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of property, plant, and equipment |  | 14420 |  | 14420 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related and other charges |  | (10184) |  | (10072) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | (9188) | (6580) | (17975) | (13367) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other corporate expenses | (26625) | (22265) | (43658) | (47037) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of definite-lived intangibles <sup>(1)</sup> | (9224) | (12591) | (18448) | (26356) |
| Operating income | $61769 | $38986 | $112029 | $56053 |

---

------

(1)Amortization of definite-lived intangibles relates to the A&D, Commercial, and RF&S Components reportable segments, but is not reviewed separately by the chief operating decision maker (CODM). For the quarters ended June 30, 2025 and July 1, 2024, amortization expense of $2,336 and $2,335, respectively, is included in cost of goods sold for the A&D reportable segment. For both the two quarters ended June 30, 2025 and July 1, 2024, amortization expense of $4,671 is included in cost of goods sold for the A&D reportable segment.

Segment operating income, as reconciled in Part I, Item 1, Note 10, *Segment Information*, of the Notes to Consolidated Condensed Financial Statements in this Report, and segment operating margin rate (segment operating income divided by segment sales) are presented in conformity with Accounting Standards Codification (ASC) Topic 280, *Segment Reporting*. These measures are reported to the CODM, who is the President and Chief Executive Officer, for purposes of making decisions about allocating resources to the segments and assessing their performance. For these reasons, these measures are excluded from the definition of non-GAAP financial measures under the SEC's Regulation G and Item 10(e) of Regulation S-K.

**A&D** 

***Segment Sales***

Segment sales for the A&D reportable segment increased $53.1 million, or 19.3%, to $327.6 million for the quarter ended June 30, 2025, from $274.5 million for the quarter ended July 1, 2024. The primary drivers of this increase were improved spending in previous defense budgets, our strong strategic program alignment, and key bookings for ongoing franchise programs, including

------

restricted programs. These increases were driven by increased sales related to missiles and munitions as well as strong demand in our Mission Systems and Specialty Assembly businesses.

Segment sales for the A&D reportable segment increased $83.4 million, or 15.1%, to $637.7 million for the two quarters ended June 30, 2025, from $554.3 million for the two quarters ended July 1, 2024. The primary drivers of the increase were as discussed in the paragraph above.

***Segment Operating Income and Margin Rate***

Segment operating income for the A&D reportable segment increased $19.8 million to $45.3 million for the quarter ended June 30, 2025, from $25.5 million for the quarter ended July 1, 2024. Segment operating margin rate for the A&D reportable segment increased to 13.8% for the quarter ended June 30, 2025, from 9.3% for the quarter ended July 1, 2024. The primary drivers of these increases were higher sales volume as discussed above, and improved operational execution.

Segment operating income for the A&D reportable segment increased $26.1 million to $86.1 million for the two quarters ended June 30, 2025, from $60.0 million for the two quarters ended July 1, 2024. Segment operating margin rate for the A&D reportable segment increased to 13.5% for the two quarters ended June 30, 2025, from 10.8% for the two quarters ended July 1, 2024. The primary drivers of these increases were higher sales volume as discussed above, and improved operational execution.

**Commercial**

***Segment Sales***

Segment sales for the Commercial reportable segment increased $72.4 million, or 22.4%, to $395.6 million for the quarter ended June 30, 2025, from $323.3 million for the quarter ended July 1, 2024. The primary driver of this increase was strong demand in our data center computing and networking end markets driven by generative AI. In addition, our medical, industrial, and instrumentation end market was also stronger as inventories and demand have normalized in this end market with growth in the industrial and instrumentation areas.

Segment sales for the Commercial reportable segment increased $121.3 million, or 20.0%, to $728.3 million for the two quarters ended June 30, 2025, from $607.1 million for the two quarters ended July 1, 2024. The primary driver of this increase was strong demand in our data center computing and networking end markets driven by generative AI, as well as normalized demand in our medical, industrial, and instrumentation end market.

***Segment Operating Income and Margin Rate***

Segment operating income for the Commercial reportable segment increased $10.4 million to $60.1 million for the quarter ended June 30, 2025, from $49.7 million for the quarter ended July 1, 2024. However, segment operating margin rate for the Commercial reportable segment slightly decreased to 15.2% for the quarter ended June 30, 2025, from 15.4% for the quarter ended July 1, 2024. The primary driver of the increase in segment operating income was higher sales volume as discussed above, while the segment operating margin rate slightly decreased due to ramp-up costs in connection with our fabrication plant in Penang, Malaysia, as well as product mix change.

Segment operating income for the Commercial reportable segment increased $24.0 million to $103.7 million for the two quarters ended June 30, 2025, from $79.8 million for the two quarters ended July 1, 2024. Segment operating margin rate for the Commercial reportable segment increased to 14.2% for the two quarters ended June 30, 2025, from 13.1% for the two quarters ended July 1, 2024. The primary drivers of these increases were higher sales volume as discussed above, and improved operational execution.

**RF&S Components**

***Segment Sales***

Segment sales for the RF&S Components reportable segment increased $1.0 million, or 11.0%, to $10.1 million for the quarter ended June 30, 2025, from $9.1 million for the quarter ended July 1, 2024. The primary driver of this increase was strong demand across the networking and medical, industrial, and instrumentation end markets.

Segment sales for the RF&S Components reportable segment increased $1.5 million, or 8.5%, to $18.9 million for the two quarters ended June 30, 2025, from $17.4 million for the two quarters ended July 1, 2024. The primary driver of this increase was strong demand across the networking and medical, industrial, and instrumentation end markets.

***Segment Operating Income and Margin Rate***

Segment operating income for the RF&S Components reportable segment increased $0.8 million to $2.9 million for the quarter ended June 30, 2025, from $2.1 million for the quarter ended July 1, 2024. Segment operating margin rate for the RF&S Components

------

reportable segment increased to 28.4% for the quarter ended June 30, 2025, from 22.6% for the quarter ended July 1, 2024. The primary drivers of these increases were higher sales volume as discussed above, and improved operational execution.

Segment operating income for the RF&S Components reportable segment increased $0.7 million to $4.5 million for the two quarters ended June 30, 2025, from $3.7 million for the two quarters ended July 1, 2024. Segment operating margin rate for the RF&S Components reportable segment increased to 23.6% for the two quarters ended June 30, 2025, from 21.3% for the two quarters ended July 1, 2024. The primary drivers of these increases were higher sales volume as discussed above, and improved operational execution.

**Liquidity and Capital Resources**

Our principal sources of liquidity have been cash provided by operations, the issuance of debt, and borrowings under our revolving credit facilities. Our principal uses of cash have been to finance capital expenditures, finance acquisitions, fund working capital requirements, repay debt obligations, and repurchase common stock. We anticipate that financing capital expenditures, financing acquisitions, funding working capital requirements, servicing debt, and repurchasing common stock will be the principal demands on our cash in the future.

Cash flow provided by operating activities during the first two quarters of 2025 was $87.1 million as compared to cash flow provided by operating activities of $85.8 million in the same period in 2024. The increase in cash flow was primarily due to an increase in net income of $36.9 million partially offset by increased investment in working capital largely driven by the timing of collections and advance payments and increased inventories related to ramping production levels.

Net cash used in investing activities during the first two quarters of 2025 was $123.5 million, primarily resulting from the use of $123.7 million for net purchases of property, plant, and equipment and other assets. Net cash used in investing activities during the first two quarters of 2024 was approximately $52.5 million, primarily resulting from the use of $88.8 million for purchases of property, plant and equipment and other assets. This was partially offset by the receipt of $29.6 million of proceeds from the sale of property, plant, and equipment and other assets primarily related to the sale of two buildings vacated by the closure of our Anaheim and Santa Clara plants and $6.7 million of proceeds from the sale of property associated with our Shanghai E-MS subsidiary.

Net cash used in financing activities during the first two quarters of 2025 was $19.8 million, reflecting the use of $17.9 million for repurchases of our common stock and $1.9 million for the repayment of long-term debt borrowings. Net cash used in financing activities during the first two quarters of 2024 was $37.1 million, reflecting the use of $34.5 million for repurchases of common stock and $2.6 million for the repayment of long-term debt borrowings.

As of June 30, 2025, we had cash and cash equivalents of approximately $448.0 million, of which approximately $137.7 million was held by our foreign subsidiaries, primarily in China, and $201.4 million of available borrowing capacity under our revolving credit facilities. Should we choose to remit cash to the United States from our foreign locations, we may incur tax obligations which would reduce the amount of cash ultimately available to the United States. However, we believe there would be no material tax expenses not previously accrued for the repatriation of this cash.

Our total 2025 capital expenditures are expected to be in the range of $235.0 million to $255.0 million, of which approximately $66.0 million relate to construction of our new plant in Syracuse, New York.

***Share Repurchases***

On May 8, 2025, our Board of Directors authorized a new share repurchase program (2025 Repurchase Program), under which we may repurchase up to $100.0 million in value of our common stock from time to time through May 7, 2027. We did not repurchase any shares of our common stock during the quarter ended June 30, 2025. During the two quarters ended June 30, 2025, under our previous two-year repurchase program that expired on May 3, 2025, we repurchased approximately 0.7 million shares of our common stock for a total cost of $17.9 million (including commissions). As of June 30, 2025, the remaining amount in value available to be repurchased under the 2025 Repurchase Program was $100.0 million.

***Long-term Debt and Letters of Credit*** 

As of June 30, 2025, we had $917.1 million of outstanding debt, net of discount and issuance costs, composed of $497.0 million of Senior Notes due 2029, $338.0 million under the Term Loan Facility due 2030 (Term Loan Facility), $80.0 million under the Asia Asset-Based Lending Credit Agreement (Asia ABL), and $2.1 million of other loans.

Pursuant to the terms of the Senior Notes due 2029 and Term Loan Facility, we are subject to certain affirmative and negative covenants, including limitations on indebtedness, corporate transactions, investments, dispositions, and restricted payments. Under the U.S. Asset-Based Lending Credit Agreement (U.S. ABL) and Asia ABL (collectively, the ABL Revolving Loans), we are also subject to various financial covenants, including leverage and fixed charge coverage ratios. As of June 30, 2025, we were in compliance with the covenants under the Senior Notes due 2029, Term Loan Facility, and ABL Revolving Loans.

------

Based on our current level of operations, we believe that cash generated from operations, cash on hand, and cash from the issuance of term and revolving debt will be adequate to meet our currently anticipated capital expenditure, debt service, and working capital needs for the next 12 months. Additional information regarding our indebtedness, including information about the credit available under our debt facilities, interest rates, and other key terms of our outstanding indebtedness, is included in Part I, Item 1, Note 8, *Long-term Debt and Letters of Credit*, of the Notes to Consolidated Condensed Financial Statements included in this Report.

***Supplier Finance Program Obligations***

We have agreements with financial institutions to facilitate payments to certain suppliers. Liabilities associated with these agreements are recorded in accounts payable on the consolidated condensed balance sheets and amounted to $12.8 million and $17.2 million as of June 30, 2025 and December 30, 2024, respectively.

**Contractual Obligations and Commitments** 

As part of our ongoing operations, we enter into contractual arrangements that obligate us to make future cash payments. These obligations impact our liquidity and capital resource needs. Our estimated future obligations consist of long-term debt obligations, interest on debt obligations, derivative liabilities, purchase obligations, and leases. As of June 30, 2025, there were no material changes outside the ordinary course of business since December 30, 2024 to our contractual obligations and commitments and the related cash requirements.

**Seasonality**

We tend to experience modest seasonal softness in the first and third quarters due to holidays and vacation periods in China and North America, respectively, which limit production leading to stronger revenue levels in the second and fourth quarters.

**Recently Issued Accounting Standards**

For a description of recently adopted and issued accounting standards, including the respective dates of adoption and the expected effects on our results of operations and financial condition, see Part I, Item 1, Note 1, *Nature of Operations and Basis of Presentation*, of the Notes to Consolidated Condensed Financial Statements included in this Report.

------

**Item 3. *Quantitative and Qualitative Disclosures About Market Risk*** 

In the normal course of business operations, we are exposed to risks associated with fluctuations in interest rates and foreign currency exchange rates. We address these risks through controlled risk management that includes the use of derivative financial instruments to economically hedge or reduce these exposures. We do not enter into derivative financial instruments for trading or speculative purposes. As of June 30, 2025, we did not have any material commodity contracts in place and believe our exposure to commodity price risk is not material.

We have not experienced any losses to date on any derivative financial instruments due to counterparty credit risk.

**Interest Rate Risks**

Our business is exposed to risk resulting from fluctuations in interest rates. Our interest expense is more sensitive to fluctuations in the general level of Term Secured Overnight Financing Rate (SOFR) interest rates than to changes in rates in other markets. Increases in interest rates would increase interest expense relating to our outstanding variable rate borrowings and increase the cost of debt. Fluctuations in interest rates can also lead to significant fluctuations in the fair value of our debt obligations.

In March 2023, we entered into a four-year pay-fixed, receive-floating (1-month Chicago Mercantile Exchange (CME) Term SOFR), interest rate swap arrangement with a notional amount of $250.0 million for the period beginning April 1, 2023 and ending on April 1, 2027. Under the terms of the interest rate swap, we pay a fixed rate of 3.49% against a portion of our Term SOFR-based debt and receive floating 1-month CME Term SOFR during the swap period.

At inception, we designated the interest rate swap as a cash flow hedge and the fair value of the interest rate swap was zero. As of June 30, 2025, the fair value of the interest rate swap was recorded as a net asset in the amount of $0.2 million, of which $1.1 million is included as a component of prepaid expenses and other current assets and $0.9 million is included as a component of other long-term liabilities. As of December 30, 2024, the fair value of the interest rate swap was recorded as an asset of $3.1 million, of which $1.8 million is included as a component of prepaid expenses and other current assets and $1.3 million is included as a component of deposits and other non-current assets. No ineffectiveness was recognized for the quarter and two quarters ended June 30, 2025. During the quarter and two quarters ended June 30, 2025, the interest rate swap decreased interest expense by $0.6 million and $1.1 million, respectively. During the quarter and two quarters ended July 1, 2024, the interest rate swap decreased interest expense by $1.2 million and $2.3 million, respectively.

See *Liquidity and Capital Resources* and *Long-term Debt and Letters of Credit* appearing in Part I, Item 2 of this Quarterly Report on Form 10-Q for further discussion of our financing facilities and capital structure. As of June 30, 2025, approximately 81.2% of our total debt was based on fixed rates. Based on our borrowings as of June 30, 2025, an assumed 100 basis point change in variable rates would cause our annual interest cost to change by $1.7 million.

**Foreign Currency Exchange Rate Risks** 

In the normal course of business, we are exposed to risks associated with fluctuations in foreign currency exchange rates related to transactions that are denominated in currencies other than our functional currencies, as well as the effects of translating amounts denominated in a foreign currency to the U.S. Dollar as a normal part of our financial reporting process. Most of our foreign operations have the U.S. Dollar as their functional currency. However, one of our China facilities utilizes the Renminbi (RMB), which results in recognition of translation adjustments included as a component of accumulated other comprehensive loss. Our foreign exchange exposure results primarily from employee-related and other costs of running our operations in foreign countries, foreign currency denominated purchases, and translation of balance sheet accounts denominated in foreign currencies. We do not engage in hedging to manage this foreign currency risk. However, we may consider the use of derivatives in the future. Our primary foreign exchange exposure is to the RMB and Malaysian Ringgit (MYR).

**Debt Instruments**

The fiscal calendar maturities of our debt instruments for the next five years and thereafter were as follows:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** |
|  | **Remaining<br>2025** | **2026** | **2027** | **2028** | **2029** | **Thereafter** | **Total** | **Fair <br>Value** | **Weighted<br>Average<br>Interest Rate** |
|  | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** | **(In thousands, except interest rates)** |
| US$ Variable Rate <sup>(1)</sup> | $1732 | $3465 | $4331 | $83465 | $2599 | $328309 | $423901 | $424761 | 6.39% |
| US$ Fixed Rate | 168 | 350 | 404 | 363 | 500419 | 445 | 502149 | 479159 | 4.01 |
| Total | $1900 | $3815 | $4735 | $83828 | $503018 | $328754 | $926050 | $903920 |  |

---

------

(1) Interest rate swap effectively fixed $250,000 of variable rate debt.

------

**Item 4. *Controls and Procedures*** 

***Evaluation of Disclosure Controls and Procedures*** 

Our management, under the supervision and with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)) under the Securities Exchange Act of 1934, as amended (Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our CEO and CFO have concluded that, as of June 30, 2025 such disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and (2) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosures.

In designing and evaluating our disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their desired control objectives, and our management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

***Changes in Internal Control over Financial Reporting*** 

We continue to expand our implementation of an enterprise resource planning (ERP) system on a worldwide basis, which is expected to improve the efficiency of the financial reporting and related transaction processes. We are in the process of rolling out the ERP system to our remaining locations to standardize the ERP system.

There were no other changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended June 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

**PART II. OTHER INFORMATION** 

**Item 1. *Legal Proceedings*** 

From time to time, we may become a party to various legal proceedings arising in the ordinary course of our business. There can be no assurance that we will prevail in any such litigation. We believe that the amount of any reasonably possible or probable loss for known matters would not be material to our financial statements; however, the outcome of these actions is inherently difficult to predict. In the event of an adverse outcome, the ultimate potential loss could have a material adverse effect on our financial condition, results of operations, or cash flows in a particular period.

**Item 1A. *Risk Factors*** 

There have been no material changes in our risk factors as previously disclosed in Part I, Item 1A, *Risk Factors*, of our Annual Report on Form 10-K for the fiscal year ended December 30, 2024.

**Item 2. *Unregistered Sales of Equity Securities and Use of Proceeds***

**Issuer Purchases of Equity Securities**

On May 8, 2025, our Board of Directors authorized a new share repurchase program, under which we may repurchase up to $100.0 million in value of our outstanding shares of common stock from time to time through May 7, 2027. Our previous two-year repurchase program expired on May 3, 2025.

We did not repurchase any shares of our common stock during the quarter ended June 30, 2025.

**Item 3. *Defaults Upon Senior Securities***

Not applicable.

**Item 4. *Mine Safety Disclosures***

Not applicable.

**Item 5. *Other Information***

**Rule 10b5-1 Trading Plans**

During the quarter ended June 30, 2025, none of our directors and/or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement" for the purchase or sale of our securities (as those terms are defined in Regulation S-K, Item 408).

------

**Item 6. *Exhibits*** 

---

| | | |
|:---|:---|:---|
| **Exhibit** |  | **Filed/Furnished** |
| **Number**  | **Exhibit Description** | **Herewith** |
| 31.1 | [<u>CEO Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</u>](ttmi-ex31_1.htm) | X |
| 31.2 | [<u>CFO Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</u>](ttmi-ex31_2.htm) | X |
| 32.1\* | [<u>CEO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</u>](ttmi-ex32_1.htm) | X |
| 32.2\* | [<u>CFO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</u>](ttmi-ex32_2.htm) | X |
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |  |
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |  |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |  |

---

------

\* Furnished herewith. The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q (Report) are not deemed filed with the Commission and are not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Report, irrespective of any general incorporation language contained in such filing.

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
|  | TTM Technologies, Inc. |
|  | /s/ Thomas T. Edman |
| Dated: August 4, 2025 | Thomas T. Edman |
|  | President and Chief Executive Officer |
|  | (Principal Executive Officer) |
|  | /s/ Daniel L. Boehle |
| Dated: August 4, 2025 | Daniel L. Boehle |
|  | Executive Vice President and Chief Financial Officer |
|  | (Principal Financial Officer and Principal Accounting Officer) |

---

------

## Exhibit 31.1

**Exhibit 31.1** 

**CERTIFICATION** 

I, Thomas T. Edman, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of TTM Technologies, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| /s/ Thomas T. Edman |
| Thomas T. Edman |
| *President and Chief Executive Officer* |
| *(Principal Executive Officer)* |

---

August 4, 2025

------

## Exhibit 31.2

**Exhibit 31.2** 

**CERTIFICATION** 

I, Daniel L. Boehle, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of TTM Technologies, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| /s/ Daniel L. Boehle |
| Daniel L. Boehle |
| *Executive Vice President and Chief Financial Officer* |
| &nbsp;&nbsp;&nbsp;&nbsp;*(Principal Financial Officer and Principal<br>Accounting Officer)* |

---

August 4, 2025

------

## Exhibit 32.1

**Exhibit 32.1** 

**CERTIFICATION PURSUANT TO** 

**18 U.S.C. SECTION 1350,** 

**AS ADOPTED PURSUANT TO** 

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Quarterly Report on Form 10-Q of TTM Technologies, Inc. (the "Company") for the quarter ended June 30, 2025, as filed with the Securities and Exchange Commission (the "Report"), I, Thomas T. Edman, President and Chief Executive Officer of the Company, certify, to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| By: | /s/ Thomas T. Edman |
|  | Thomas T. Edman |
|  | *President and Chief Executive Officer* |
|  | *(Principal Executive Officer)* |

---

August 4, 2025

------

## Exhibit 32.2

**Exhibit 32.2** 

**CERTIFICATION PURSUANT TO** 

**18 U.S.C. SECTION 1350,** 

**AS ADOPTED PURSUANT TO** 

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Quarterly Report on Form 10-Q of TTM Technologies, Inc. (the "Company") for the quarter ended June 30, 2025, as filed with the Securities and Exchange Commission (the "Report"), I, Daniel L. Boehle, Executive Vice President and Chief Financial Officer of the Company, certify, to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| By: | /s/ Daniel L. Boehle |
|  | Daniel L. Boehle |
|  | *Executive Vice President and Chief Financial Officer* |
|  | &nbsp;&nbsp;&nbsp;&nbsp;*(Principal Financial Officer and Principal<br>Accounting Officer)* |

---

August 4, 2025

------